Eupraxia Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

TSX:EPRX Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
18 Aug 23	BuyCA$50,001	Amanda Malone	Individual	7,143	CA$7.00
18 Aug 23	BuyCA$100,002	James Helliwell	Individual	14,286	CA$7.00
18 Aug 23	BuyCA$19,999	Michael Wilmink	Individual	2,857	CA$7.00
18 Aug 23	BuyCA$28,000	Simon Pimstone	Individual	4,000	CA$7.00
18 Aug 23	BuyCA$10,010	Richard Glickman	Individual	1,430	CA$7.00
18 Aug 23	BuyCA$25,200	Paul Geyer	Individual	3,600	CA$7.00
18 Aug 23	BuyCA$35,000	Paul Brennan	Individual	5,000	CA$7.00
18 Aug 23	BuyCA$525,000	John Montalbano	Individual	75,000	CA$7.00
18 Aug 23	BuyCA$56,000	Mark Kowalski	Individual	8,000	CA$7.00
18 Aug 23	BuyCA$100,002	Bruce Cousins	Individual	14,286	CA$7.00

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 63.8%.

Top 14 shareholders own 19.3% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
7.82%	Manchester Management Company, LLC	2,784,049	CA$10.3m	0%	33.09%
3.36%	John Montalbano	1,197,666	CA$4.4m	0%	no data
3.11%	Pathfinder Asset Management Limited	1,106,500	CA$4.1m	0%	21.47%
1.89%	James Helliwell	674,012	CA$2.5m	0%	no data
0.96%	Paul Geyer	340,346	CA$1.3m	0%	no data
0.78%	Douglas Johnson	277,500	CA$1.0m	0%	no data
0.62%	Michael Wilmink	219,425	CA$809.7k	0%	no data
0.32%	Bruce Cousins	114,286	CA$421.7k	0%	no data
0.16%	Ninepoint Partners LP	55,900	CA$206.3k	-10.6%	0.01%
0.13%	Amanda Malone	46,343	CA$171.0k	0%	no data
0.076%	Paul Brennan	27,200	CA$100.4k	0%	no data
0.039%	Richard Glickman	13,930	CA$51.4k	0%	no data
0.024%	Simon Pimstone	8,626	CA$31.8k	0%	no data
0.022%	Mark Kowalski	8,000	CA$29.5k	0%	no data